Hazmat incident at Fort Worth garbage site sends 1 to hospital, 17 evaluated, officials say
Just before 8 a.m., Fort Worth fire crews responded to a garbage site in the 6200 block of Elliott Reeder Road after a call concerning a "cloud" seen at the facility.
According to the Fort Worth Fire Department, one person was transported to a hospital, and at least 17 others were checked out at the scene and are all expected to be OK.
The department is investigating what caused the incident.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
UnitedHealth Group (UNH) Responds to the Department of Justice
UnitedHealth Group Incorporated (NYSE:UNH) is one of the top low volatility healthcare stocks to buy now. On July 24, UnitedHealth Group Incorporated (NYSE:UNH) released a statement responding to the Department of Justice after a review of the media reports about investigations into specific aspects of its involvement in the Medicare program. A senior healthcare professional giving advice to a patient in a clinic. UnitedHealth Group Incorporated (NYSE:UNH) stated that it has now begun complying with the formal criminal and civil requests from the Department, and has 'full confidence in its practices and is committed to working cooperatively with the Department throughout this process'. It added that UnitedHealth Group Incorporated (NYSE:UNH) has a historical record of 'responsible conduct and effective compliance,' with independent CMS audits showing that its practices are ranked 'among the most accurate in the industry.' Management stated that after a decade-long civil challenge by the Department to aspects of the company's Medicare Advantage business, 'a court-appointed Special Master concluded there was no evidence to support claims of wrongdoing'. UnitedHealth Group Incorporated (NYSE:UNH) has launched its own initiative to provide confidence and transparency to stakeholders, focusing on conducting 'third-party reviews of policies, practices, and associated processes and performance metrics for risk assessment coding, managed care practices, and pharmacy services.' UnitedHealth Group Incorporated (NYSE:UNH) provides healthcare coverage, data consultancy, and software services. It operates through the OptumRx, OptumInsight, OptumHealth, and UnitedHealthCare segments, which have solid operations. While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Medscape
14 minutes ago
- Medscape
Cancer Care Costs High Among Privately Insured Patients
TOPLINE: A recent analysis found that privately insured US patients with newly diagnosed cancer, especially those with more advanced disease, had 'substantial out-of-pocket costs.' Monthly out-of-pocket costs among these patients increased by a mean of almost $600, on average, but increased to nearly $720 per month for those with stage IV disease. METHODOLOGY: Out-of-pocket costs for cancer care in the US are rising, but most research has focused on Medicare beneficiaries. It's important to understand privately insured patients' financial burdens, especially with cancer rates growing among younger Americans. Researchers conducted a retrospective study of 19,656 patients with cancer, using a dataset that links claims from a large private insurer to the Surveillance, Epidemiology, and End Results cancer registry. Overall, 74.1% had breast cancer, 14.5% had colorectal cancer, and 11.4% had lung cancer. Analyses also included 26,502 individuals without cancer who were assigned pseudo – diagnosis date. Monthly out-of-pocket costs (copays, co-insurance, and deductibles) were calculated from claims and inflation-adjusted to 2024 US dollars. TAKEAWAY: After a cancer diagnosis, monthly out-of-pocket costs rose by $592, on average. Those added costs increased with disease stage, from $462 per month for stage 0 cancer to $720 per month for stage IV cancer. Out-of-pocket costs spiked in the month of diagnosis and remained elevated for 6 months compared with those in individuals without cancer — totaling an average of $4145 in cumulative additional costs (over 7 months). IN PRACTICE: 'In this cohort study, patients with private insurance were found to have high OOPCs [out-of-pocket costs] after an incident diagnosis of cancer, and those with the most advanced cancer had the highest OOPCs,' the authors wrote. 'The variability in OOPCs based on cancer stage underscores the need for policies such as paid sick leave, that address both insurance continuity and financial assistance, especially for patients with more advanced cancer.' SOURCE: This study, led by Liam Rose, PhD, Stanford University School of Medicine, Palo Alto, California, was published online in JAMA Network Open. LIMITATIONS: Differential insurance attrition could have affected the results: Patients with stage IV cancer were most likely to drop their coverage. The study could only capture direct medical costs, which misses other potential financial burdens, such as lost income and travel expenses. DISCLOSURES: This study received funding support through a grant from the American Cancer Society. One author reported receiving grants from the Department of Veterans Affairs and National Institutes of Health during the conduct of the study. No other disclosures were reported. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Yahoo
17 minutes ago
- Yahoo
This is why you shouldn't put make-up on children
Would you dab perfume on a six-month-old? Paint their tiny nails with polish that contains formaldehyde? Dust bronzer onto their cheeks? An investigation by the Times has found that babies and toddlers are routinely exposed to adult cosmetic products, including fragranced sprays, nail polish and even black henna tattoos. While these may sound harmless – or even Instagram-friendly – the science tells a more concerning story. Infant skin is biologically different from adult skin: it's thinner, more absorbent and still developing. Exposure to certain products can lead to immediate problems like irritation or allergic reactions, and in some cases, may carry longer term health-risks such as hormone disruption. This isn't a new concern. A 2019 study found that every two hours in the US, a child was taken to hospital because of accidental exposure to cosmetic products. Newborn skin has the same number of layers as adult skin but those layers are up to 30% thinner. That thinner barrier makes it easier for substances, including chemicals, to penetrate through to deeper tissues and the bloodstream. Young skin also has a higher water content and produces less sebum (the natural oil that protects and moisturises the skin). This makes it more prone to water loss, dryness and irritation, particularly when exposed to fragrances or creams not formulated for infants. The skin's microbiome – its protective layer of beneficial microbes – also takes time to develop. By age three, a child's skin finishes establishing its first microbiome. Before then, products applied to the skin can disrupt this delicate balance. At puberty, the skin's structure and microbiome change again, altering how it responds to products. The investigation found that bronzers and nail polish were being used on young children. These products often contain harmful or even carcinogenic chemicals, such as formaldehyde, toluene and dibutyl phthalate. Toluene is a known neurotoxin, and dibutyl phthalate is an endocrine disruptor – a chemical that can interfere with hormone function, potentially affecting growth, development and fertility. Both substances can more easily pass through infants' thinner, more permeable skin. Even low-level exposure to formaldehyde, such as from furniture or air pollution, has been linked to higher rates of lower respiratory infections in children (that's infections affecting the lungs, airways and windpipe). Irritating ingredients In the US, one in three adults experiences skin or respiratory symptoms after exposure to fragranced products. If adults are reacting, it's no surprise that newborns and children with their developing immune systems are at even greater risk. Perfumes often contain alcohol and volatile compounds that dry out the skin, leading to redness, itching and discomfort. Certain skincare ingredients have also been studied for their potential to affect hormones, trigger allergies or pose long-term health concerns: alkylphenols used in detergents and cosmetics may disrupt hormone activity antimicrobials such as triclosan can interfere with thyroid hormones and contribute to antibiotic resistance bisphenols, (BPA widely used in packaging are linked to hormone disruption. cyclosiloxanes (D4 and D5) may accumulate in the body and affect hormonal balance ethanolamines can react with other ingredients to form nitrosamines, some of which are potential carcinogens parabens are preservatives that mimic oestrogen, though some studies suggest minimal risk at low doses phthalates used in fragrances and plastics are linked to reproductive toxicity, especially in early-life exposures benzophenone is found in many sunscreens and some forms may act as allergens and hormone disruptors. While many of these ingredients are permitted in regulated concentrations, some researchers warn of a 'cocktail effect': the cumulative impact of daily exposure to multiple chemicals, especially in young, developing bodies. Temporary tattoos Temporary tattoos, particularly black henna, are popular on holidays but they aren't always safe. Black henna is a common cause of contact dermatitis in children and may contain para-phenylenediamine (PPD), a chemical approved for use in hair dyes but not for direct application to skin. PPD exposure can cause severe allergic reactions and, in rare cases, cancer. Children may develop hypopigmentation – pale patches where colour is lost – or, in adults, hyperpigmentation that can last for months or become permanent. Worryingly, children exposed to PPD may experience more severe reactions later in life if they use hair dyes containing the same compound. This can sometimes lead to hospitalisation or even fatal anaphylaxis. Because of these risks, European legislation prohibits PPD from being applied directly to the skin, eyebrows, or eyelashes. 'Natural' doesn't mean harmless Products marketed as 'natural' or 'clean' can also cause allergic reactions. Propolis (bee glue), for instance, is found in many natural skincare products but causes contact dermatitis in up to 16% of children. A study found an average of 4.5 contact allergens per product in 'natural' skincare ranges. Out of 1,651 'natural' personal care products on the US market, only 96 (5.8%) were free from contact allergens. Even claims like 'dermatologically tested' don't guarantee safety; they simply mean the product was tested on skin, not that it's free from allergens. Babies and young children aren't just miniature adults. Their skin is still developing and is more vulnerable to irritation, chemical absorption and systemic effects: substances that penetrate the skin can enter the bloodstream and potentially affect organs or biological systems throughout the body. Applying adult-targeted products, or even well-meaning 'natural' alternatives, can therefore carry real risks. Adverse reactions can appear as rashes, scaling or itchiness and, in severe cases, blistering or crusting. Respiratory symptoms like coughing or wheezing should always be investigated by a medical professional. When in doubt, keep it simple. Limit what goes on your child's skin, especially in the early years. Adam Taylor is a Professor of Anatomy, Lancaster University This article is republished from The Conversation under a Creative Commons license. Read the original article.
